Sergio P. De Filippis

Rome, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 67 publications

Current Practices in the Treatment of Dual Diagnosis: Insights from a Nationwide Survey of Italian Psychiatrists on Pharmacological and Nonpharmacological Approaches, Challenges, and Limitations.

Current Practices in the Treatment of Dual Diagnosis: Insights from a Nationwide Survey of Italian Psychiatrists on Pharmacological and Nonpharmacological Approaches, Challenges, and Limitations.

Journal: Journal of dual diagnosis

Published: July 01, 2026

Brexpiprazole vs. Aripiprazole in Patients with Schizophrenia with or Without Comorbid Substance Use Disorder: A 12-Month Real-World Naturalistic Study of Efficacy.

Brexpiprazole vs. Aripiprazole in Patients with Schizophrenia with or Without Comorbid Substance Use Disorder: A 12-Month Real-World Naturalistic Study of Efficacy.

Journal: Brain sciences

Published: May 28, 2026

Lithium Formulations in Clinical Practice.

Lithium Formulations in Clinical Practice.

Journal: Current neuropharmacology

Published: February 03, 2026

Trazodone in neurology, a new life for an old molecule - an updated, comprehensive, systematic review of clinical trials.

Trazodone in neurology, a new life for an old molecule - an updated, comprehensive, systematic review of clinical trials.

Journal: International journal of psychiatry in clinical practice

Published: October 13, 2025

Retrospective multicenter cohort study of slow titration of vortioxetine to mitigate early nausea in major depression.

Retrospective multicenter cohort study of slow titration of vortioxetine to mitigate early nausea in major depression.

Journal: Journal of affective disorders

Published: August 29, 2025

Clozapine in treatment-resistant early-onset schizophrenia: A two-year follow-up retrospective observational study.

Clozapine in treatment-resistant early-onset schizophrenia: A two-year follow-up retrospective observational study.

Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Published: June 21, 2025

Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.

Effectiveness of repeated Esketamine nasal spray administration on anhedonic symptoms in treatment-resistant bipolar and unipolar depression: A secondary analysis from the REAL-ESK study group.

Journal: Psychiatry research

Published: June 11, 2025

A Case-Control Study On Corpus Callosum Volume and Clinical Correlates in Treatment-Resistant and Responsive Schizophrenia Patients: Addressing MRI Analysis within Single-Subject and a Novel Artificial Intelligence Paradigm.

A Case-Control Study On Corpus Callosum Volume and Clinical Correlates in Treatment-Resistant and Responsive Schizophrenia Patients: Addressing MRI Analysis within Single-Subject and a Novel Artificial Intelligence Paradigm.

Journal: Current neuropharmacology

Published: May 12, 2025

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Patient Experience with Intranasal Esketamine in Treatment-Resistant Depression: Insights from a Multicentric Italian Study (REAL-ESKperience).

Journal: Journal of personalized medicine

Published: March 06, 2025

Dealing with Early-Onset Schizophrenia and the Role of Lurasidone: An Expert Opinion.

Dealing with Early-Onset Schizophrenia and the Role of Lurasidone: An Expert Opinion.

Journal: Current neuropharmacology

Published: February 14, 2025

Dealing with Early-Onset Schizophrenia and the Role of Lurasidone: An Expert Opinion.

Dealing with Early-Onset Schizophrenia and the Role of Lurasidone: An Expert Opinion.

Journal: Current neuropharmacology

Published: February 14, 2025

Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels.

Optimising Aripiprazole Long-Acting Injectable: A Comparative Study of One- and Two-Injection Start Regimens in Schizophrenia with and Without Substance Use Disorders and Relationship to Early Serum Levels.

Journal: International journal of molecular sciences

Published: December 20, 2024

Showing 1-12 of 67

Last Updated: 09/26/2026